Cala Health

Stanford, United States Founded: 2013 • Age: 13 yrs
Wearable neuromodulation devices for essential tremor relief are developed.
Request Access

About Cala Health

Cala Health is a company based in Stanford (United States) founded in 2013 by Kate Rosenbluth.. Cala Health has raised $257.05 million across 8 funding rounds from investors including Novartis, Johnson & Johnson and SK biopharmaceuticals. Cala Health offers products and services including Cala kIQ System, Cala TAPS Therapy, and Cala Trio System. Cala Health operates in a competitive market with competitors including Ceribell, Kernel, PhotoPharmics, Rhaeos and Spark Biomedical, among others.

  • Headquarter Stanford, United States
  • Founders Kate Rosenbluth
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cala Health, Inc
Operational Areas
Healthcare → Health Technology & Digital Health
Technology → Extended, Virtual & Augmented Reality
Healthcare → Healthcare Products & Supplies
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $257.05 M (USD)

    in 8 rounds

  • Latest Funding Round
    $50 M (USD), Series D

    Oct 20, 2025

  • Investors
    Novartis

    & 24 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cala Health

Cala Health offers a comprehensive portfolio of products and services, including Cala kIQ System, Cala TAPS Therapy, and Cala Trio System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

FDA-cleared device for reducing hand tremors in essential tremor patients.

Non-invasive stimulation therapy to alleviate action tremors effectively.

Wearable solution for tremor relief in Parkinson’s disease users.

People of Cala Health
Headcount 50-200
Employee Profiles 14
Employee Profiles
People
Steve Higa
VP of Manufacturing & Quality
People
Bernard E. Shay
General Counsel
People
Deanna Harshbarger
VP of Product
People
Tim Gallagher
Chief Financial Officer

Unlock access to complete

Funding Insights of Cala Health

Cala Health has successfully raised a total of $257.05M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series D — $50.0M
  • First Round
  • Investors Count 25
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2025 Amount Series D - Cala Health Valuation

investors

Dec, 2024 Amount Series D - Cala Health Valuation Vertex Growth , Nexus NeuroTech Ventures
May, 2022 Amount Series D - Cala Health Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cala Health

Cala Health has secured backing from 25 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Johnson & Johnson and SK biopharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early & late stage investments focused PE & VC firm
Founded Year Domain Location
Investments are focused on neurotechnology for brain disorders.
Founded Year Domain Location
Stage-agnostic investments in US life sciences are pursued.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cala Health

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cala Health

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cala Health Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cala Health

Cala Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, Kernel, PhotoPharmics, Rhaeos and Spark Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Portable EEG devices for point-of-care seizure diagnosis are provided.
domain founded_year HQ Location
Multimodal brain measurement technology is developed for neuromedicine applications.
domain founded_year HQ Location
Non-invasive phototherapy for Parkinson's disease is developed.
domain founded_year HQ Location
Noninvasive device developed for CSF monitoring and hydrocephalus management.
domain founded_year HQ Location
Neurostimulation devices for opioid withdrawal symptoms are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cala Health

Frequently Asked Questions about Cala Health

When was Cala Health founded?

Cala Health was founded in 2013.

Where is Cala Health located?

Cala Health is headquartered in Stanford, United States. It is registered at Stanford, California, United States.

Who is the current CEO of Cala Health?

Deanna Harshbarger is the current CEO of Cala Health.

Is Cala Health a funded company?

Cala Health is a funded company, having raised a total of $257.05M across 8 funding rounds to date.

What does Cala Health do?

Cala Health was founded in 2013 in Stanford, United States, and operates in the medical devices sector focused on neuromodulation. A watch-like wearable device combined with an implantable sensor is developed to stimulate peripheral nerves and reduce hand tremors in adults with essential tremors. Additionally, a portable device equipped with sensors is created to monitor patient physical movements.

Who are the top competitors of Cala Health?

Cala Health's top competitors include Ceribell, Magnus Medical and PhotoPharmics.

What products or services does Cala Health offer?

Cala Health offers Cala kIQ System, Cala TAPS Therapy, and Cala Trio System.

Who are Cala Health's investors?

Cala Health has 25 investors. Key investors include Novartis, Johnson & Johnson, SK biopharmaceuticals, Vertex Growth, and Nexus NeuroTech Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available